A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
Public ClinicalTrials.gov record NCT02615184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE
Study identification
- NCT ID
- NCT02615184
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- Dexlansoprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2023
- Primary completion
- Apr 12, 2026
- Completion
- Apr 12, 2026
- Last update posted
- May 5, 2026
2023 – 2026
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama | Mobile | Alabama | 36604 | — |
| University of California San Francisco | San Francisco | California | 94158 | — |
| D&H National Research Centers | Miami | Florida | 33155 | — |
| Children's Center for Digestive Health Care, LLC | Atlanta | Georgia | 30342 | — |
| Gastrointestinal Associates, PA | Flowood | Mississippi | 39232 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Measurable Outcome Research | Oklahoma City | Oklahoma | 73112 | — |
| GI for Kids | Knoxville | Tennessee | 37922 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
| Envision Clinical Research, LLC | Laredo | Texas | 78041 | — |
| The Children's Hospital of The King's Daughters | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02615184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02615184 live on ClinicalTrials.gov.